St Jude Medical has received CE Mark approval for its FlexAbility ablation catheter, a new ablation technology used by electrophysiologists, to treat cardiac arrhythmias.
The approval of next-generation ablation catheter further strengthens the company’s ablation technology portfolio, which also includes the TactiCath contact-force sensing irrigated ablation catheter.
St Jude Medical has also announced the first use of the FlexAbility ablation catheter that combines an irrigated flexible catheter tip with a new design and handle.
The first use of the catheter, post-approval, took place at IdealMed Unidade Hospitalar de Coimbra in Portugal and at the Hopital Haut-Leveque in Bordeaux, France.
The company said that the next-generation flexible tip technology helps in reducing complications related with ablation procedures through its ability to bend and conform to the cardiac anatomy, decreasing the amount of pressure distributed to a patient’s heart wall while simultaneously increasing the stability of therapy delivery.
St Jude Medical group president Eric Fain said: “The goal of the FlexAbility catheter was to bring the most advanced irrigated ablation solution to the electrophysiology market.
“Because we worked with industry thought leaders throughout the development of this technology, we are confident that its completely redesigned handle and shaft, along with its unique flexible tip, will become a leading ablation technology that addresses the broad needs of electrophysiologists across the wide spectrum of patient anatomies.”
Ablation catheters are thin, flexible wires used to help treat irregular heartbeats that impair the heart’s ability to effectively pump blood throughout the body.
FlexAbility catheter features a handle and shaft that provides improved manoeuverability, allowing electrophysiologists to reach challenging anatomic locations within their patients.
The technology has been designed to offer optimal irrigation flow over the entire tip for improved cooling, reducing risk factors related with the delivery of therapy.
The company said that data produced by the FlexAbility ablation catheter are displayed on the EnSite Velocity System, a cardiac mapping and navigation system.
Image: The CE Mark approval of FlexAbility ablation catheter further strengthens the company’s ablation technology portfolio. Photo: courtesy of St Jude Medical/Business Wire.